SCHEMBL879231

SCHEMBL879231

Cc1cc(O)ccc1NC(=O)CSc1nnc(C(F)(F)F)n1-c1ccc(C2CC2)c2ccccc12

nearest known ligand 0.49

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SLC22A12 Q96S37 17/20 0.49
CYP2C9 P11712 2/20 0.49
CYP2C19 P33261 2/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
SLC22A11 Q9NSA0 1/20 0.49
SLC2A9 Q9NRM0 2/20 0.48
SMN1; SMN2 Q16637 1/20 0.44
ALDH1A1 P00352 1/20 0.42
MAPT P10636 1/20 0.42
THRB P10828 1/20 0.42
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12378964 0.93 THRB (0.49) SLC22A12CYP2C9CYP2C19CYP1A2CYP3A4
SCHEMBL10029331 0.91 SLC22A12 (0.49) SLC22A12CYP2C9CYP2C19CYP1A2CYP3A4
SCHEMBL12010037 0.82 SLC22A12 (0.53) SLC22A12CYP2C9CYP2C19CYP1A2CYP3A4
SCHEMBL10227725 0.80 SLC22A12 (0.73) SLC22A12CYP2C9CYP2C19CYP1A2CYP3A4
SCHEMBL10029207 0.80 SLC22A12 (0.53) SLC22A12CYP2C9CYP2C19CYP1A2CYP3A4
SCHEMBL1719573 0.79 SLC22A12 (0.65) SLC22A12CYP2C9CYP2C19CYP1A2CYP3A4
SCHEMBL253614 0.78 SLC22A12 (0.62) SLC22A12CYP2C9CYP2C19CYP1A2CYP3A4
SCHEMBL249261 0.77 SLC22A12 (0.66) SLC22A12CYP2C9CYP2C19CYP1A2CYP3A4
SCHEMBL12056187 0.75 SLC22A12 (0.64) SLC22A12CYP2C9CYP2C19CYP1A2CYP3A4
SCHEMBL10029197 0.74 SLC22A12 (0.51) SLC22A12CYP2C9CYP2C19CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609917-A1 Triazolyl alpha -mercaptoacetanilides as inhibitors of HIV reverse transcriptase Ardea Biosciences, Inc. (US) 2013-07-03 EP disclosed
EP-2402011-B1 S-triazolyl alpha-mercaptoacetanilides as inhibitors of HIV reverse transcriptase ARDEA BIOSCIENCES INC (US) 2012-11-14 EP disclosed
EP-2433633-A1 Triazolyl alpha -mercaptoacetanildes as inhibitors of HIV reverse transcriptase Ardea Biosciences, Inc. (US) 2012-03-28 EP disclosed
EP-2402011-A1 Intermediates in the synthesis of S-triazolyl alpha-mercaptoacetanildes as inhibitors of HIV reverse transcriptase Ardea Biosciences, Inc. (US) 2012-01-04 EP disclosed
EP-2135608-B1 S-triazolyl alpha -mercaptoacetanilides as inhibitors of HIV reverse transcriptase ARDEA BIOSCIENCES INC (US) 2011-10-12 EP disclosed